Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Take LSD, stay out of prison? Huge study links psychedelic use to reduced recidivism

by Eric W. Dolan
January 8, 2014
in Psychopharmacology
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Psilocybe mushroomsA study of more than 25,000 people under community corrections supervision suggests the use of psychedelic drugs like LSD can keep people out of prison.

The research is the first in 40 years to examine whether drugs like LSD and “magic” mushrooms can help reform criminals.

“Our results provide a notable exception to the robust positive link between substance use and criminal behavior,” the researchers from the University of Alabama at Birmingham and Johns Hopkins University School of Medicine wrote in their study, which was published in the January issue of the Journal of Psychopharmacology.

“They add to both the older and emerging body of data indicating beneficial effects of hallucinogen interventions, and run counter to the legal classification as well as popular perception of hallucinogens as categorically harmful substances with no therapeutic potential.”

Psychedelic substances piqued the interest of researchers beginning in the 1950s. Studies indicated that the drugs could be combined with psychotherapy to treat a number of conditions, including alcoholism and drug addiction.

But scientific investigations into the therapeutic potential of LSD, psilocybin, mescaline, and other psychedelic drugs ground to a halt in the 1970s, when they were outlawed by the federal Controlled Substances Act.

“Offenders may be especially likely to benefit from hallucinogen treatment because involvement in the criminal justice system often results from drug-seeking behavior and impulsive conduct exacerbated by compulsive substance use,” the researchers explained in the study.

From 2002 to 2007, the researchers collected data on 25,622 individuals under community corrections supervision in Treatment Accountability for Safer Communities (TASC), a program for individuals with a history of drug abuse.

Only about 1 percent of those in the program were diagnosed with a hallucinogen use disorder. Cannabis use disorders, cocaine use disorders, and alcohol use disorders were the most common diagnoses in the group.

The researchers found those diagnosed with a hallucinogen use disorder were less likely to fail the TASC program compared to those without a hallucinogen use disorder. That means those with a hallucinogen use disorder were less likely to violate TASC rules or other legal requirements, less likely to fail to appear in court, and less likely to be incarcerated.

The study controlled for a large number of potentially confounding factors, including race, employment, marital status, age, criminal history, drug abuse history, gender, educational attainment, and more.

“The current findings should not at all be interpreted as advocating for recreational hallucinogen use. Nevertheless, they demonstrate that, in a real-world, substance-related intervention setting, hallucinogen use is associated with a lower probability of poor outcome,” the researchers wrote.

“We believe this calls for the continued scientific investigation of this unique class of substances.”

The study was authored by Peter S. Hendricks, C. Brendan Clark, Matthew W. Johnson, Kevin R. Fontaine, and Karen L. Cropsey.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Addiction

Scientists map how alcohol changes bodily sensations

June 14, 2025

A new study suggests that people who feel fewer bodily sensations while intoxicated may be at higher risk for alcohol misuse. Using bodily maps and heartbeat tasks, researchers linked internal awareness to physiological effects and subjective feelings of intoxication.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails
Neuroscience discoveries: 5 new studies offer unexpected insights into the brain
Alzheimer's Disease

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

June 13, 2025

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Read moreDetails
Brain connectivity maps shed light on the synergistic effects of meditation and psilocybin
Psychedelic Drugs

Psychedelic experiences can both cause and resolve spiritual struggles, study suggests

June 12, 2025

A new study has found that people frequently described both relief from spiritual tension and the emergence of new spiritual struggles following psychedelic use.

Read moreDetails
Meta-analysis highlights potential of psilocybin therapy for treatment-resistant depression
Depression

Psilocybin therapy shows similar benefits for patients with and without recent antidepressant use

June 11, 2025

A new study finds that individuals with treatment-resistant depression experienced similar improvements from psilocybin-assisted psychotherapy whether or not they had recently discontinued antidepressant medications.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Attachment anxiety mediates effects of childhood abuse on parental confidence

Scientists demonstrate superior cognitive benefits of outdoor vs indoor physical activity

Racial insecurity helped shield Trump from Republican backlash after Capitol riot, study suggests

Frequent pornography use linked to altered brain connectivity and impaired cognitive performance

Childhood trauma linked to changes in brain structure and connectivity, study finds

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

COVID-19 coverage linked to rise in anti-Asian sentiment, especially among Trump supporters

Some dark personality traits may help buffer against depression, new psychology research suggests

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy